Ironwood Pharmaceuticals | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Agios Pharmaceuticals USD 76.25M 177.48M 2024-12
Almirall EUR 329.41M 15.11M 2024-06
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
Amarin USD 156.94M 58.98M 2024-09
Ardelyx USD 48.65M 8.78M 2024-12
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 5.49B 691M 2024-12
Charles River Laboratories USD 194.61M 15.56M 2024-12
Exact Sciences USD 5.34M 748K 2024-12
Halozyme Therapeutics USD 115.85M 38.47M 2024-12
Incyte USD 1.69B 383.72M 2024-12
Ironwood Pharmaceuticals USD 88.56M 348K 2024-12
MacroGenics USD 182.84M 3.22M 2024-12
Moderna USD 1.93B 283M 2024-12
Myriad Genetics USD 102.4M 2.5M 2024-12
Pacira USD 276.77M 30.81M 2024-12
PTC Therapeutics USD 779.71M 253.71M 2024-12
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
Takeda JPY 494.13B 364.89B 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12



Ironwood Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.